NCT00588068Recruiting
Molecular Characterization of Neuroblastic Tumor: Correlation With Clinical Outcome
Source: ClinicalTrials.gov · Last updated 5 Oct 2026
Brief summary (registry, in English)
The purpose of this study is to find out the genetic and biochemical makeup of your neuroblastic tumor, which influences its aggressiveness and the suitable therapy. These research studies include surface marker analysis, cytogenetics, cancer genes,genome sequencing, tumor growth-related genes and tumor growth in test tubes. Your blood, marrow, and hematopoietic stem cell samples will also be tested for tumors or leukemia cells, and your serum tested for anti-tumor antibodies.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 2070 (estimated)
- First submitted
- 24 Dec 2007
- Start date
- 26 Sept 2000
- Primary completion date
- Sept 2027
- Lead sponsor
- Memorial Sloan Kettering Cancer Center
- Diseases
- Neuroblastoma, Childhood cancers
- NCT number
- NCT00588068
What you commit to
- Study type: Observational
- Planned participants: 2070
- From 26 Sept 2000 to the primary completion date, Sept 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- None
Who the study is looking for
- Neuroblastic tumors diagnosed in accordance with the International Neuroblastoma Staging System
- OR
- Clinically suspected neuroblastic tumors.
- PK DRAW INCLUSION CRITERIA (FOR PK DRAWS ONLY):
- PK Draw Inclusion Criteria
- Patients who receive naxitamab as part of their standard of care
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Memorial Sloan-Kettering Cancer Center Coordinator of this site? Confirm its status | New York | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.